Article
Proposal of a prediction model describing the metabolic interaction between warfarin and sorafenib using a population pharmacokinetic approach.
International journal of clinical pharmacology and therapeutics - 1 Mar 2021
Asari Kazuhiko, Takahashi Harumi
Abstract excerpt
OBJECTIVE: We attempted to examine the applicability of a population pharmacokinetic-pharmacodynamic (PK-PD) model describing the metabolic interaction between warfarin and sorafenib due to CYP2C9 inhibition and to predict the plasma concentrations of sorafenib and S-warfarin, the international normalized ratio (INR), and the optimal maintenance dose of warfarin in the presence of sorafenib in vivo. MATERIALS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
